178 related articles for article (PubMed ID: 26501112)
41. A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring.
Keller MJ; Mesquita PM; Marzinke MA; Teller R; Espinoza L; Atrio JM; Lo Y; Frank B; Srinivasan S; Fredricks DN; Rabe L; Anderson PL; Hendrix CW; Kiser PF; Herold BC
AIDS; 2016 Mar; 30(5):743-51. PubMed ID: 26605514
[TBL] [Abstract][Full Text] [Related]
42. Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles.
Cobb DA; Smith N; Deodhar S; Bade AN; Gautam N; Shetty BLD; McMillan J; Alnouti Y; Cohen SM; Gendelman HE; Edagwa B
Nat Commun; 2021 Sep; 12(1):5458. PubMed ID: 34531390
[TBL] [Abstract][Full Text] [Related]
43. Evaluating the association of single-nucleotide polymorphisms with tenofovir exposure in a diverse prospective cohort of women living with HIV.
Baxi SM; Greenblatt RM; Bacchetti P; Cohen M; DeHovitz JA; Anastos K; Gange SJ; Young MA; Aouizerat BE
Pharmacogenomics J; 2018 Apr; 18(2):245-250. PubMed ID: 28462920
[TBL] [Abstract][Full Text] [Related]
44. Safety and efficacy of tenofovir/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention.
Dezzutti CS; Shetler C; Mahalingam A; Ugaonkar SR; Gwozdz G; Buckheit KW; Buckheit RW
Antiviral Res; 2012 Nov; 96(2):221-5. PubMed ID: 22940075
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and Evaluation of Anti-HIV Activity of Mono- and Di-Substituted Phosphonamidate Conjugates of Tenofovir.
Qureshi A; Ouattara LA; El-Sayed NS; Verma A; Doncel GF; Choudhary MI; Siddiqui H; Parang K
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889320
[TBL] [Abstract][Full Text] [Related]
46. Engagement in Mental Health Care is Associated with Higher Cumulative Drug Exposure and Adherence to Antiretroviral Therapy.
Coyle RP; Schneck CD; Morrow M; Coleman SS; Gardner EM; Zheng JH; Ellison L; Bushman LR; Kiser JJ; Mawhinney S; Anderson PL; Castillo-Mancilla JR
AIDS Behav; 2019 Dec; 23(12):3493-3502. PubMed ID: 30798457
[TBL] [Abstract][Full Text] [Related]
47. Sex hormones regulate tenofovir-diphosphate in female reproductive tract cells in culture.
Shen Z; Fahey JV; Bodwell JE; Rodriguez-Garcia M; Kashuba AD; Wira CR
PLoS One; 2014; 9(6):e100863. PubMed ID: 24978212
[TBL] [Abstract][Full Text] [Related]
48. Simultaneous quantification of emtricitabine and tenofovir nucleotides in peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry.
Jansen RS; Rosing H; Kromdijk W; ter Heine R; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):621-7. PubMed ID: 20122883
[TBL] [Abstract][Full Text] [Related]
49. Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV Infection.
Xiao P; Gumber S; Marzinke MA; Date AA; Hoang T; Hanes J; Ensign LM; Wang L; Rohan L; Fuchs EJ; Hendrix C; Villinger F
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084755
[TBL] [Abstract][Full Text] [Related]
50. Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma.
Kraft JC; McConnachie LA; Koehn J; Kinman L; Collins C; Shen DD; Collier AC; Ho RJ
AIDS; 2017 Mar; 31(6):765-770. PubMed ID: 28099191
[TBL] [Abstract][Full Text] [Related]
51. Antiretroviral agents in pre-exposure prophylaxis: emerging and advanced trends in HIV prevention.
Yap PK; Loo Xin GL; Tan YY; Chellian J; Gupta G; Liew YK; Collet T; Dua K; Chellappan DK
J Pharm Pharmacol; 2019 Sep; 71(9):1339-1352. PubMed ID: 31144296
[TBL] [Abstract][Full Text] [Related]
52. Hypo-osmolar rectal douche tenofovir formulation prevents simian/human immunodeficiency virus acquisition in macaques.
Xiao P; Gumber S; Marzinke MA; Hoang T; Myers R; Date AA; Hanes J; Ensign LM; Wang L; Rohan LC; Cone R; Fuchs EJ; Hendrix CW; Villinger F
JCI Insight; 2022 Dec; 7(23):. PubMed ID: 36477356
[TBL] [Abstract][Full Text] [Related]
53. Short Communication: Specimen Processing Impacts Tissue Tenofovir Pharmacokinetic Measurements.
Bakshi RP; Breakey J; Manohar M; Jois B; Fuchs EJ; Marzinke MA
AIDS Res Hum Retroviruses; 2018 Apr; 34(4):354-356. PubMed ID: 29258331
[TBL] [Abstract][Full Text] [Related]
54. Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Pyles RB; Guthrie KM; Dawson L; Olive TJ; Butkyavichene I; Churchman SA; Cortez JM; Fanter R; Gunawardana M; Miller CS; Yang F; Rosen RK; Vargas SE; Baum MM
PLoS Med; 2018 Sep; 15(9):e1002655. PubMed ID: 30265679
[TBL] [Abstract][Full Text] [Related]
55. Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.
Havens PL; Stephensen CB; Van Loan MD; Schuster GU; Woodhouse LR; Flynn PM; Gordon CM; Pan CG; Rutledge B; Liu N; Wilson CM; Hazra R; Hosek SG; Anderson PL; Seifert SM; Kapogiannis BG; Mulligan K;
Clin Infect Dis; 2017 Feb; 64(3):317-325. PubMed ID: 28013265
[TBL] [Abstract][Full Text] [Related]
56. Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.
Castillo-Mancilla J; Seifert S; Campbell K; Coleman S; McAllister K; Zheng JH; Gardner EM; Liu A; Glidden DV; Grant R; Hosek S; Wilson CM; Bushman LR; MaWhinney S; Anderson PL
Antimicrob Agents Chemother; 2016 Nov; 60(11):6692-6697. PubMed ID: 27572401
[TBL] [Abstract][Full Text] [Related]
57. Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrations.
Olanrewaju AO; Sullivan BP; Bardon AR; Lo TJ; Cressey TR; Posner JD; Drain PK
Virol J; 2021 Apr; 18(1):77. PubMed ID: 33858461
[TBL] [Abstract][Full Text] [Related]
58. A New Approach to Developing Long-Acting Injectable Formulations of Anti-HIV Drugs: Poly(Ethylene Phosphoric Acid) Block Copolymers Increase the Efficiency of Tenofovir against HIV-1 in MT-4 Cells.
Nifant'ev I; Siniavin A; Karamov E; Kosarev M; Kovalchuk S; Turgiev A; Nametkin S; Bagrov V; Tavtorkin A; Ivchenko P
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396968
[TBL] [Abstract][Full Text] [Related]
59. Validation of an LC-MS/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spots.
Schauer AP; Sykes C; Cottrell ML; Prince H; Kashuba ADM
J Pharm Biomed Anal; 2018 Feb; 149():40-45. PubMed ID: 29100029
[TBL] [Abstract][Full Text] [Related]
60. Tenofovir Activation is Diminished in the Brain and Liver of Creatine Kinase Brain-Type Knockout Mice.
Eberhard CD; Mosher EP; Bumpus NN; Orsburn BC
bioRxiv; 2023 Sep; ():. PubMed ID: 37808667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
